COVID-19 Clinical Trials in Los Angeles, California

4 studies are recruiting for covid-19 in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

   The goal of this clinical trial is to test two investigational COVID-19 booster vaccines, called CoTend-s3BXBB and CoTend-BXBB, in healthy volunteers ages 40-64. The CoTend-s3BXBB vaccine includes a component called "s3", which was designed to improve the body's response to the vaccine. CoTend-BXBB…

   Stage

   Phase 1

   Ages

   40 to 64

   Site

   UCLA Westwood, Los Angeles, California

   Locations

   2 in total

   Run by

   Kara Chew

   See if you can join NCT06810934 on ClinicalTrials.gov

2. Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

   The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertional malaise, effect of breathlessness on daily activities, post-COVID-19 symptom burden, and biomar…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of California, Los Angeles (UCLA), Los Angeles, California

   Locations

   17 in total

   Run by

   Wes Ely

   See if you can join NCT06631287 on ClinicalTrials.gov

3. Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

   Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronaviru…

   Stage

   Not phased

   Ages

   18 to 60

   Site

   Department of Emergency Medicine, Children's Hospital of Los Angeles, Los Angeles, California

   Locations

   4 in total

   Run by

   KidSIM Simulation Program

   See if you can join NCT05868239 on ClinicalTrials.gov

4. EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

   The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/r…

   Stage

   Phase 3

   Ages

   0 to 17

   Site

   Children's Hospital Los Angeles, Los Angeles, California

   Locations

   73 in total

   Run by

   Pfizer

   See if you can join NCT05261139 on ClinicalTrials.gov